참고문헌
- Schupp CJ, Kleber JB, Gunther P, et al. Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome. Pediatr Dermatol 2011;28: 640-4. https://doi.org/10.1111/j.1525-1470.2011.01569.x
- Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006;118: 882-7. https://doi.org/10.1542/peds.2006-0413
- Ogawa R, Neligan PC. Benign cutaneous and soft-tissue tumors. In: Ogawa R, editor. Benign and malignant nonmelanocytic tumors of the skin and soft tissue. Edinburgh: Elsevier Health Sciences; 2018. p. 707-42.
- Dubois J, Alison M. Vascular anomalies: what a radiologist needs to know. Pediatr Radiol 2010;40:895-905. https://doi.org/10.1007/s00247-010-1621-y
- Nakayama H. Clinical and histological studies of the classification and the natural course of the strawberry mark. J Dermatol 1981;8:277-91. https://doi.org/10.1111/j.1346-8138.1981.tb02546.x
- North PE, Waner M, Mizeracki A, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001;137:559-70.
- Sirachainan N, Lekanan W, Thammagasorn Y, et al. Response to propranolol in infantile hemangioma. Pediatr Int 2016;58:662-5. https://doi.org/10.1111/ped.12992
- Barrio VR, Drolet BA. Treatment of hemangiomas of infancy. Dermatol Ther 2005;18:151-9. https://doi.org/10.1111/j.1529-8019.2005.05018.x
- Enjolras O, Breviere GM, Roger G, et al. Vincristine treatment for function- and life-threatening infantile hemangioma. Arch Pediatr 2004;11:99-107. https://doi.org/10.1016/j.arcped.2003.10.014
- Zarem HA, Edgerton MT. Induced resolution of cavernous hemangiomas following prednisolone therapy. Plast Reconstr Surg 1967;39:76-83. https://doi.org/10.1097/00006534-196701000-00010
- Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol 2002; 138:1567-76.
- Leaute-Labreze C, Hoeger P, Mazereeuw-Hautier J, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med 2015;372:735-46. https://doi.org/10.1056/NEJMoa1404710
- Leaute-Labreze C, Boccara O, Degrugillier-Chopinet C, et al. Safety of oral propranolol for the treatment of infantile hemangioma: a systematic review. Pediatrics 2016;1384: e20160353.
- Ji Y, Chen S, Xu C, et al. The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action. Br J Dermatol 2015;172:24-32. https://doi.org/10.1111/bjd.13388
- Aletaha M, Salour H, Bagheri A, et al. Oral propranolol for treatment of pediatric capillary hemangiomas. J Ophthalmic Vis Res 2012;7:130-3.
- Holland KE, Frieden IJ, Frommelt PC, et al. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 2010;146:775-8.
- International Color Consortium. Image technology colour management: architecture, profile format, and data structure. dSpecification ICC. 1: 2004-10 (Profile version 4.2. 0.0) [Internet]. Reston, VA: ICC; c2004 [cited 2018 Nov 7]. Available from http://www.color.org/icc1v42_2006-05.pdf.
- Izadpanah A, Izadpanah A, Kanevsky J, et al. Propranolol versus corticosteroids in the treatment of infantile hemangioma: a systematic review and meta-analysis. Plast Reconstr Surg 2013;131:601-13. https://doi.org/10.1097/PRS.0b013e31827c6fab
- Helfand M, Peterson K. Drug class review on beta adrenergic blockers. Portland: Oregon Health & Science University; 2005.
- Nguyen J, Fay A. Pharmacologic therapy for periocular infantile hemangiomas: a review of the literature. Semin Ophthalmol 2009;24:178-84. https://doi.org/10.1080/08820530902805602
- Denoyelle F, Leboulanger N, Enjolras O, et al. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 2009;73: 1168-72. https://doi.org/10.1016/j.ijporl.2009.04.025
- Kim KM, Min, DH, Jung, HL, et al. Propranolol as a first-line treatment for pediatric hemangioma: outcome of a single institution over one year. Clinical Pediatric Hematology-Oncology 2016;23:97-104. https://doi.org/10.15264/cpho.2016.23.2.97
- Wedgeworth E, Glover M, Irvine AD, et al. Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol in the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey. Br J Dermatol 2016;174:594-601. https://doi.org/10.1111/bjd.14233
- Fost NC, Esterly NB. Successful treatment of juvenile hemangiomas with prednisone. J Pediatr 1968;72:351-7. https://doi.org/10.1016/S0022-3476(68)80208-2
- Boon LM, MacDonald DM, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 1999;104:1616-23. https://doi.org/10.1097/00006534-199911000-00002
피인용 문헌
- Infantile Hemangioma: An Updated Review vol.16, pp.None, 2018, https://doi.org/10.2174/1573396316666200508100038
- The effectiveness of oral propranolol for infantile hemangioma on the head and neck region: A case series vol.84, pp.None, 2018, https://doi.org/10.1016/j.ijscr.2021.106120